SSY Group Limited (2005.HK)

HKD 3.31

(-2.93%)

EBITDA Summary of SSY Group Limited

  • SSY Group Limited's latest annual EBITDA in 2023 was 2.11 Billion HKD , up 11.41% from previous year.
  • SSY Group Limited's latest quarterly EBITDA in 2024 Q2 was 1.08 Billion HKD , down 0.0% from previous quarter.
  • SSY Group Limited reported an annual EBITDA of 1.85 Billion HKD in 2022, up 33.7% from previous year.
  • SSY Group Limited reported an annual EBITDA of 1.39 Billion HKD in 2021, up 28.78% from previous year.
  • SSY Group Limited reported a quarterly EBITDA of 945.28 Million HKD for 2023 Q2, down 0.0% from previous quarter.
  • SSY Group Limited reported a quarterly EBITDA of 950.43 Million HKD for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of SSY Group Limited (2023 - 2004)

Historical Annual EBITDA of SSY Group Limited (2023 - 2004)

Year EBITDA EBITDA Growth
2023 2.11 Billion HKD 11.41%
2022 1.85 Billion HKD 33.7%
2021 1.39 Billion HKD 28.78%
2020 1.09 Billion HKD -33.87%
2019 1.69 Billion HKD 9.68%
2018 1.38 Billion HKD 25.54%
2017 1.11 Billion HKD 21.74%
2016 906.13 Million HKD 20.7%
2015 750.75 Million HKD -2.97%
2014 785.37 Million HKD 12.61%
2013 689.46 Million HKD 32.43%
2012 522.18 Million HKD 279.65%
2011 140.63 Million HKD -68.44%
2010 434.32 Million HKD 14.71%
2009 377.35 Million HKD 70.3%
2008 221.69 Million HKD 29.5%
2007 171.19 Million HKD 76.75%
2006 129.81 Million HKD -26.23%
2005 131.28 Million HKD 2.54%
2004 128.03 Million HKD 0.0%

Peer EBITDA Comparison of SSY Group Limited

Name EBITDA EBITDA Difference
Pak Fah Yeow International Limited 150.4 Million HKD -1305.955%
Grand Pharmaceutical Group Limited 2.96 Billion HKD 28.72%
Extrawell Pharmaceutical Holdings Limited -129.51 Million HKD 1732.61%
Wai Yuen Tong Medicine Holdings Limited 113.79 Million HKD -1758.166%
Qianhai Health Holdings Limited -50.22 Million HKD 4309.831%
Lee's Pharmaceutical Holdings Limited 109.82 Million HKD -1825.474%
Essex Bio-Technology Limited 418.37 Million HKD -405.419%
Tongfang Kontafarma Holdings Limited 76.63 Million HKD -2659.328%
PuraPharm Corporation Limited -26.16 Million HKD 8180.385%
JBM (Healthcare) Limited 204.39 Million HKD -934.569%
Jacobson Pharma Corporation Limited 429.92 Million HKD -391.848%
China Resources Pharmaceutical Group Limited 15.43 Billion HKD 86.297%